Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 4/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 3/20 | 0.41 |
| ▸ | PARP1 | P09874 | 5/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.39 |
| ▸ | MELK | Q14680 | 1/20 | 0.39 |
| ▸ | STK24 | Q9Y6E0 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10871309 | 0.79 | ALDH1A1 (0.46) | ALDH1A1TDP1HPGDCYP3A4TSHR | |
| SCHEMBL16745341 | 0.77 | ALDH1A1 (0.44) | ALDH1A1TDP1HPGDCYP3A4TSHR | |
| SCHEMBL16745339 | 0.77 | ALDH1A1 (0.44) | ALDH1A1TDP1HPGDCYP3A4TSHR | |
| SCHEMBL13211650 | 0.75 | PABPC1 (0.39) | ALDH1A1TDP1HPGDCYP3A4TSHR | |
| SCHEMBL16745345 | 0.74 | ALDH1A1 (0.42) | ALDH1A1TDP1HPGDCYP3A4TSHR | |
| SCHEMBL12340285 | 0.74 | MCL1 (0.36) | ALDH1A1TDP1HPGDCYP3A4TSHR | |
| SCHEMBL29788293 | 0.73 | ALDH1A1 (0.65) | ALDH1A1TDP1HPGDCYP3A4TSHR | |
| SCHEMBL16623896 | 0.73 | ALDH1A1 (0.65) | ALDH1A1TDP1HPGDCYP3A4TSHR | |
| SCHEMBL30565110 | 0.73 | ALDH1A1 (0.65) | ALDH1A1TDP1HPGDCYP3A4TSHR | |
| SCHEMBL16745347 | 0.73 | ALDH1A1 (0.41) | ALDH1A1TDP1HPGDCYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9725571-B2 | Method of making nanoporous structures | MESODYNAMICS, INC. (US) | 2017-08-08 | — | — | US | disclosed |
| US-20160236993-A1 | Method of Making Functionalized Nanoporous Structures | MESODYNAMICS, INC. | 2016-08-18 | — | — | US | disclosed |
| US-20160200632-A1 | Method of Making Nanoporous Structures | MESODYNAMICS, INC. | 2016-07-14 | — | — | US | disclosed |
| US-20160003841-A1 | INTEGRATED HIGH THROUGHPUT SYSTEM FOR THE ANALYSIS OF BIOMOLECULES | INTRINSIC BIOPROBES, INC. | 2016-01-07 | — | — | US | disclosed |
| US-9134306-B2 | Integrated high throughput system for the analysis of biomolecules | INTRINSIC BIOPROBES, INC. (US) | 2015-09-15 | — | — | US | disclosed |
| US-20140193311-A1 | INTEGRATED HIGH THROUGHPUT SYSTEM FOR THE ANALYSIS OF BIOMOLECULES | INTRINSIC BIOPROBES, INC. (US) | 2014-07-10 | — | — | US | disclosed |
| US-8574434-B2 | Integrated high throughput system for the analysis of biomolecules | INTRINSIC BIOPROBES, INC. (US) | 2013-11-05 | — | — | US | disclosed |
| US-20130153479-A1 | INTEGRATED HIGH THROUGHPUT SYSTEM FOR THE ANALYSIS OF BIOMOLECULES | INTRINSIC BIOPROBES, INC. (US) | 2013-06-20 | — | — | US | disclosed |
| US-8372279-B2 | Integrated high throughput system for the analysis of biomolecules | INTRINSIC BIOPROBES, INC. (US) | 2013-02-12 | — | — | US | disclosed |
| WO-2012135034-A9 | FIBER WITH MICROBIAL REMOVAL, MICRO-BIOCIDAL, OR STATIC GROWTH CAPABILITY | RECEPTORS LLC (US) | 2012-12-27 | — | — | WO | disclosed |
| US-20050003555-A1 | AN INTEGRATED HIGH THROUGHPUT SYSTEM FOR THE ANALYSIS OF BIOMOLECULES | INTRINSIC BIOPROBES, INC. | 2005-01-06 | — | — | US | disclosed |
| US-20040265843-A1 | INTEGRATED HIGH THROUGHPUT SYSTEM FOR THE ANALYSIS OF BIOMOLECULES | INTRINSIC BIOPROBES, INC. | 2004-12-30 | — | — | US | disclosed |
| US-20040265844-A1 | INTEGRATED HIGH THROUGHPUT SYSTEM FOR THE ANALYSIS OF BIOMOLECULES | INTRINSIC BIOPROBES, INC. | 2004-12-30 | — | — | US | disclosed |
| US-6783672-B2 | RECEPTIVE SUPPORT FOR USE IN THE DETECTION OF PREFERENTIAL BIOPOLYMERS | INTRINSIC BIOPROBES, INC. | 2004-08-31 | — | — | US | disclosed |
| EP-1362126-A4 | AN INTEGRATED HIGH THROUGHPUT SYSTEM FOR THE ANALYSIS OF BIOMOLECULES | TUBBS KEMMONS A (US) | 2004-07-21 | — | — | EP | disclosed |
| EP-1362126-A2 | AN INTEGRATED HIGH THROUGHPUT SYSTEM FOR THE ANALYSIS OF BIOMOLECULES | Tubbs, Kemmons A. (US) | 2003-11-19 | — | — | EP | disclosed |
| WO-2002082051-A2 | AN INTEGRATED HIGH THROUGHPUT SYSTEM FOR THE ANALYSIS OF BIOMOLECULES | TUBBS KEMMONS A (US) | 2002-10-17 | — | — | WO | disclosed |
| US-20020094566-A1 | Receptive support for use in the detection of preferential biopolymers | INTRINSIC BIOPROBES, INC. | 2002-07-18 | — | — | US | disclosed |
| US-4071409-A | POLYMERIC ISOCYANATE COUPLER | CORNING GLASS WORKS (US) | 1978-01-31 | — | — | US | disclosed |
| US-3933997-A | RADIOACTIVITY, SILANE COUPLING AGENT | CORNING GLASS WORKS (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160236993-A1 | Method of Making Functionalized Nanoporous Structures | MSN, CD44, ILK | ALDH1A1 4607/4885TDP1 4457/4885HPGD 2267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.